All In Biotech

Free tool

FAERS Monitor: Epidiolex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210365 or its brand name (Epidiolex, Cannabidiol). Reports on generic versions are filed under their own applications.

Reports

24,103

Serious

14,267

59% of reports

Hospitalization

7,388

Death reported

1,929

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure6,169
  • hospitalisation2,670
  • off label use2,520
  • product use in unapproved indication1,809
  • diarrhoea1,776
  • drug ineffective1,445
  • death1,374
  • somnolence1,340
  • fatigue1,231
  • product dose omission issue1,191
  • weight decreased890
  • weight increased845
  • vomiting753
  • decreased appetite735
  • nausea678

Reports by year received

View as table
YearReports
20101
20143
201528
201635
201792
2018232
20193,463
20203,556
20214,386
20223,787
20232,469
20242,045
20252,201
20261,805

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,056 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal6,16949.248.1277,095
hospitalisationSignal2,67015.414.935,610
product use in unapproved indicationSignal1,8096.46.18,290
somnolenceSignal1,3405.85.55,385
product dose omission issueSignal1,1913.53.42,195
weight increasedSignal8453.33.11,363
weight decreasedSignal8902.82.61,029
decreased appetiteSignal7352.82.6834
off label useSignal2,5202.52.42,393
diarrhoeaSignal1,7762.42.31,498
vomiting7531.41.387
death1,3741.41.3158
fatigue1,2311.41.3133
drug ineffective1,4451.00.93
nausea6780.70.760

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.